Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dongli Yang

Showing results (41-50 of 63) with videos related to

Pageof 7
Sort By:
Frontiers in Pharmacology|June 26, 2020
Shenmai Injection Protects Against Doxorubicin-Induced Cardiotoxicity <i>via</i> Maintaining Mitochondrial HomeostasisLin Li, Jinghao Li, Qilong Wang, et al.
Molecular Cancer Therapeutics|June 22, 2022
Targeting Therapeutic Resistance and Multinucleate Giant Cells in CCNE1-Amplified HR-Proficient Ovarian CancerShoumei Bai, Sarah E Taylor, Mohd Azrin Jamalruddin, et al.
Molecular Cancer|August 27, 2024
Assessment of SWI/SNF chromatin remodeling complex related genes as potential biomarkers and therapeutic targets in pan-cancerKai Zhuang, Lishan Wang, Chengyu Lu, et al.
The Journal of Pharmacy and Pharmacology|June 3, 2026
Mai Guan Fu Kang capsule attenuates coronary heart disease via PI3K/Akt signaling pathway and gut microbiotaHuizi Shangguan, Zexuan Sun, Xin Wang, et al.
Theranostics|March 5, 2021
Aldehyde dehydrogenase inhibitors promote DNA damage in ovarian cancer and synergize with ATM/ATR inhibitorsEdward Grimley, Alexander J Cole, Thong T Luong, et al.
Cancers|May 14, 2022
Shifting the Soil: Metformin Treatment Decreases the Protumorigenic Tumor Microenvironment in Epithelial Ovarian CancerSarah E Taylor, Daniel K Chan, Dongli Yang, et al.
Molecular Cancer Therapeutics|November 15, 2017
Therapeutic Impact of Nanoparticle Therapy Targeting Tumor-Associated MacrophagesCourtney A Penn, Kun Yang, Hong Zong, et al.
Diabetology & Metabolic Syndrome|July 16, 2025
Synergistic effects of NF-κB1 and inflammatory pathway polymorphisms on hypertension and dyslipidemia susceptibility in type 2 diabetesChao Zuo, Jing Cheng, Dongli Yang, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|November 12, 2025
VEGFA-centric angiogenic genetic variants drive hypertension and dyslipidaemia susceptibility in type 2 diabetes mellitus: A multilocus synergistic cohort studyChao Zuo, Hailian Chen, Xiang Lu, et al.
BMC Complementary Medicine and Therapies|April 16, 2020
Investigation of cardiovascular protective effect of Shenmai injection by network pharmacology and pharmacological evaluationLin Li, Dongli Yang, Jinghao Li, et al.
Pageof 7

Showing results (41-50 of 63) with videos related to

Sort By:
Pageof 7
Frontiers in Pharmacology|June 26, 2020
Shenmai Injection Protects Against Doxorubicin-Induced Cardiotoxicity <i>via</i> Maintaining Mitochondrial HomeostasisLin Li, Jinghao Li, Qilong Wang, et al.
Molecular Cancer Therapeutics|June 22, 2022
Targeting Therapeutic Resistance and Multinucleate Giant Cells in CCNE1-Amplified HR-Proficient Ovarian CancerShoumei Bai, Sarah E Taylor, Mohd Azrin Jamalruddin, et al.
Molecular Cancer|August 27, 2024
Assessment of SWI/SNF chromatin remodeling complex related genes as potential biomarkers and therapeutic targets in pan-cancerKai Zhuang, Lishan Wang, Chengyu Lu, et al.
The Journal of Pharmacy and Pharmacology|June 3, 2026
Mai Guan Fu Kang capsule attenuates coronary heart disease via PI3K/Akt signaling pathway and gut microbiotaHuizi Shangguan, Zexuan Sun, Xin Wang, et al.
Theranostics|March 5, 2021
Aldehyde dehydrogenase inhibitors promote DNA damage in ovarian cancer and synergize with ATM/ATR inhibitorsEdward Grimley, Alexander J Cole, Thong T Luong, et al.
Cancers|May 14, 2022
Shifting the Soil: Metformin Treatment Decreases the Protumorigenic Tumor Microenvironment in Epithelial Ovarian CancerSarah E Taylor, Daniel K Chan, Dongli Yang, et al.
Molecular Cancer Therapeutics|November 15, 2017
Therapeutic Impact of Nanoparticle Therapy Targeting Tumor-Associated MacrophagesCourtney A Penn, Kun Yang, Hong Zong, et al.
Diabetology & Metabolic Syndrome|July 16, 2025
Synergistic effects of NF-κB1 and inflammatory pathway polymorphisms on hypertension and dyslipidemia susceptibility in type 2 diabetesChao Zuo, Jing Cheng, Dongli Yang, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|November 12, 2025
VEGFA-centric angiogenic genetic variants drive hypertension and dyslipidaemia susceptibility in type 2 diabetes mellitus: A multilocus synergistic cohort studyChao Zuo, Hailian Chen, Xiang Lu, et al.
BMC Complementary Medicine and Therapies|April 16, 2020
Investigation of cardiovascular protective effect of Shenmai injection by network pharmacology and pharmacological evaluationLin Li, Dongli Yang, Jinghao Li, et al.
Pageof 7